Concord Biotech Limited (NSE:CONCORDBIO)

Concord Biotech Stock Forecast

Stock Price Forecast

According to 5 analysts polled by S&P Global, Concord Biotech stock has a consensus rating of "Buy" and an average price target of ₹1,196. The average 1-year stock price forecast is 6.91% lower than the current stock price, while the lowest is ₹1,020 (-20.61%) and the highest is ₹1,380 (+7.41%).

Price Target: ₹1,196 (-6.91%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	₹1,020	₹1,196	₹1,260	₹1,380
Change	-20.61%	-6.91%	-1.93%	+7.41%

Analyst Ratings

The average analyst rating for Concord Biotech stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Nov '25	Dec '25	Jan '26	Feb '26	Apr '26	Jun '26
Strong Buy	2	2	2	2	2	2
Buy	2	2	2	2	2	1
Hold	2	2	2	2	1	1
Sell	0	0	0	0	0	1
Strong Sell	0	0	0	0	0	0
Total	6	6	6	6	5	5

Financial Forecast

Revenue This Year

12.54B

Increased by 18.85%

from 10.55B

Revenue Next Year

15.67B

Increased by 24.96%

from 12.54B

EPS This Year

31.56

Increased by 26.16%

from 25.01

EPS Next Year

42.17

Increased by 33.62%

from 31.56

Fiscal Year	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Mar 31, 2022	Mar 31, 2023	Mar 31, 2024	Mar 31, 2025	Mar 31, 2026	Mar 31, 2027
Revenue	7.13B	8.53B	10.17B	12.00B	10.55B	12.54B
Revenue Growth	15.56%	19.67%	19.20%	18.01%	-12.10%	18.85%
Gross Profit	5.41B	6.61B	6.67B	7.68B	6.93B	9.54B
Gross Margin	75.89%	77.49%	65.61%	64.03%	65.70%	76.10%
Operating Income	2.29B	3.00B	3.87B	4.60B	2.93B	3.74B
Net Income	1.75B	2.40B	3.08B	3.72B	2.61B	3.38B
EPS	-	-	-	-	25.01	31.56
EPS Growth	-	-	-	-	-29.58%	26.16%
Forward PE	-	-	43.46	41.55	26.26	40.71
Dividend / Share	5.12	6.83	8.75	10.70	7.55	9.73
Dividend Growth	-	33.40%	28.11%	22.29%	-29.44%	28.92%
Free Cash Flow	188.91M	505.95M	1.18B	926.14M	1.14B	2.68B
No. Analysts	-	-	-	-	-	4

EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.

Revenue Forecast

Revenue	2027	2028	2029
High	13.1B
Avg	12.5B
Low	12.1B

Revenue Growth

Revenue Growth	2027	2028	2029
High	23.9%
Avg	18.9%
Low	15.0%

EPS Forecast

EPS	2027	2028	2029
High	33.98
Avg	31.56
Low	29.40

EPS Growth

EPS Growth	2027	2028	2029
High	35.8%
Avg	26.2%
Low	17.5%

Data Source: S&P Global Market Intelligence

Price targets, consensus ratings and financial forecasts are provided by S&P Global Market Intelligence. Price targets and consensus ratings update every hour to every three days.

Data Sources Report a data error